What changed
$BNS — BUY 📊 | 6 MONTHS THESIS
🎯 latest | Rev $9.6B | EPS $2.02 vs $1.94 🟢
💡 Market expects flat-to-modest growth with ongoing Latin American risk, but the earnings beat suggests resilience and potential for positive credit migration; consensus EPS estimates for FY2024 ($7.80) are too low and will be revised up, narrowing the valuation discount.
📉 Reward/risk: 2.01:1
🏢 Business Quality: 7/10 - Strong Canadian banking franchise with diversified Pacific Alliance footprint, solid capital ratios, and a 6.5% yield; however, emerging-market exposure adds volatility and credit risk.
📊 Valuation: cheap - P/E 10.4x (TTM) vs Canadian bank peers avg 12x and BNS's 5-year avg of 11x; P/B est.
🔮 Catalyst: Analyst estimate revision cycle post-earnings, next quarterly pre-announcement in ~2 months
💰 Entry: $83.99, stop $81.5, target $89.0
📊 Our read: BUY. Full analysis →
https://stockduty.xyz/s/BNS0614